GeoVax Receives Patent for VLP Ebola Vaccine
GeoVax Labs, Inc. today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for Patent ...
Tag: Lassa Fever
Early Clinical Signs of Severe Lassa Fever
Lassa fever causes multisystem disease and has a fatality rate <70%. Severe cases exhibit abnormal coagulation, endothelial barrier disruption, and ...
CEPI-EDCTP Seeks Proposals for Lassa Virus Vaccines
Lassa virus (LASV) has been added to the WHO R&D Blueprint list of diseases for which there is an urgent ...
Lassa Fever: Why There’s a Call to Declare a Health Emergency in Nigeria
The Nigerian Academy of Science has called for the current outbreak of Lassa fever in Africa’s most populous nation to ...
CDC Updates Monkeypox Travel Alert for Nigeria
The U.S. Centers for Disease Control and Prevention (CDC) updates an existing Level 1 Travel Alert for Monkeypox in the ...
Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus
Inovio Pharmaceuticals, Inc. today announced the Coalition for Epidemic Preparedness Innovations (CEPI) has awarded Inovio a grant of up to ...
British Nationals Evacuated from Sierra Leone for Lassa Fever Contact Monitoring
Three British nationals have been brought back to the UK from Sierra Leone for medical assessment after coming into close contact with ...
Deforestation Leading to More Infectious Diseases in Humans
60 percent of new infectious diseases that emerge in people—including HIV, Ebola , and Nipah, all of which originated in ...
U.S. Supporting Ecological Surveillance for Special Pathogens in Sierra Leone
The U.S. Centers for Disease Control and Prevention has issued a funding opportunity in support of improved vector surveillance and ...
Naval Research Laboratory Seeks to Advance Field Diagnostics of Infectious Agents
The Naval Research Laboratory (NRL) is seeking partners to advance technology developed for in vitro diagnostic devices that are amenable ...
Fundamental Research to Counter Biological, Chemical, and Nuclear Weapons
The Defense Threat Reduction Agency (DTRA) seeks to identify, adopt, and adapt emerging, existing and revolutionary sciences that may demonstrate ...
NIAID Backs VesiculoVax Vaccine for Ebola, Marburg, and Lassa Viruses
Profectus BioSciences, Inc. has received a contract for up to $22.25 million from the National Institute of Allergy and Infectious ...
New Coalition for Epidemic Preparedness Sets Sights on MERS-CoV, Lassa and Nipah
A global coalition to create new vaccines for emerging infectious diseases, designed to help give the world an insurance policy ...
Zalgen and NOWDx Collaborate on Rapid Diagnostics for Ebola, Tropical Diseases
Credit: Shutterstock Zalgen Labs recently announced that it has entered into a series of agreements with NOWDiagnostics (NOWDx) to collaborate ...
WHO Update: Lassa Fever in Germany
The World Health Organization today provided an update on the two cases of Lassa fever reported from German health authorities. ...
Advanced Development of Filovirus and Lassa Fever Vaccines
The National Institute of Allergy and Infectious Diseases (NIAID) is seeking proposals for advanced development of multivalent vaccines against Ebola ...
Handicapping Ebola to Buy Immune System Time to Respond
The Ebola virus acts fast. The course of infection, from exposure to recovery, or death, can take as little as ...
RFI – Vaccine Candidates and Technologies for Filoviruses
The National Institute of Allergy and Infectious Diseases (NIAID) is seeking information from pharmaceutical and biopharmaceutical product developers on multivalent ...
CDC Confirms Lassa Fever in Death of New Jersey Man
A man died of Lassa fever at a hospital in New Jersey on Monday after returning from Liberia this month, ...
Development of MAGPIX Immunoassays for Lassa, Chikungunya, Ebola
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) is soliciting development and deployment of MAGPIX-based immunoassays which will ...
